Safety and Performance of New 2-piece Ostomy Product Concept Compared With SenSura Click in Subjects With Ileostomy
NCT ID: NCT01800890
Last Updated: 2014-08-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2013-02-28
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
NCT02675634
Investigating the Safety and Performance of SenSura Test Product in Subjects With Ileostomy
NCT02887144
Investigation of the Performance and Safety of New 1-piece Open Ostomy Appliances Compared to Standard Care
NCT01957384
Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study
NCT02266849
Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation
NCT02137642
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment sequence 1
Subjects randomised to Treatment sequence 1 will test three different products:
1. Coloplast A
2. Coloplast B
3. SenSura Click
The subjects test the three test products in a randomized order: ABS; BSA, SAB
Coloplast A
Coloplast A is a newly developed 2-piece ostomy appliance
Coloplast B
Coloplast B is a newly developed 2-piece ostomy appliance
SenSura Click
The comparator product is the commercial and CE-marked SenSura Click (2-piece) manufactured by Coloplast A/S.
Treatment sequence 2
Subjects randomised to Treatment sequence 2 will test three different products:
1. Coloplast C (C)
2. Coloplast B (B)
3. SenSura Click (S)
The subjects test the three test products in a randomized order: CBS; BSC, SCB
Coloplast B
Coloplast B is a newly developed 2-piece ostomy appliance
Coloplast C
Coloplast C is a newly developed 2-piece ostomy appliance
SenSura Click
The comparator product is the commercial and CE-marked SenSura Click (2-piece) manufactured by Coloplast A/S.
Treatment sequence 3
Subjects randomised to Treatment sequence 3 will test three different products:
1. Coloplast A (A)
2. Coloplast C (C)
3. SenSura Click (S)
The subjects test the three test products in a randomized order: ACS; CSA, SAC
Coloplast A
Coloplast A is a newly developed 2-piece ostomy appliance
Coloplast C
Coloplast C is a newly developed 2-piece ostomy appliance
SenSura Click
The comparator product is the commercial and CE-marked SenSura Click (2-piece) manufactured by Coloplast A/S.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coloplast A
Coloplast A is a newly developed 2-piece ostomy appliance
Coloplast B
Coloplast B is a newly developed 2-piece ostomy appliance
Coloplast C
Coloplast C is a newly developed 2-piece ostomy appliance
SenSura Click
The comparator product is the commercial and CE-marked SenSura Click (2-piece) manufactured by Coloplast A/S.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Be at least 18 years of age and have full legal capacity.
3. Be able to handle the appliances themselves
4. Have an ileostomy with a diameter between 15 and 40 mm.
5. Have had their ostomy for at least three months.
6. Use minimum 1 baseplate every third day.
7. Currently use 2-piece flat mechanical coupling product with open bag and a coupling size in the inter val of 43-55mm (both extremes included)
8. Must be able to use custom cut product
9. Accept to test three 2-piece products within the study.
10. Negative result of a pregnancy test for women of childbearing age.
Exclusion Criteria
2. Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
3. Currently receiving or have within the past month received local or systemic steroid treatment in the peristomal area.
4. Are pregnant or breastfeeding.
5. Participating in other interventional clinical investigations or have previously participated in this investigation.
6. More than three days wear time as usual change pattern.
7. Currently using ostomy belt
8. Currently using extended wear product (Sensura Xpro, Assura TERA, Dansac NovaLife X3, Hollister Flextend, Convatec Durahesive)
9. Have a loop ileostomy
10. Known hypersensitivity towards any of the test products
11. Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coloplast A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Carter, MSc
Role: STUDY_CHAIR
Coloplast A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coloplast A/S
Humlebæk, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP234
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.